- Home
- PEPG vs ECBK Comparison
PEPG vs ECBK Comparison
Compare PEPG & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PEPG | ECBK |
|---|---|---|
| Founded | 2018 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.5M | 182.5M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PEPG | ECBK |
|---|---|---|
| Price | $2.40 | $21.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.19 | N/A |
| AVG Volume (30 Days) | ★ 948.7K | 7.4K |
| Earning Date | 11-16-2026 | 10-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.61 | ★ 95.83 |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $598,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $27.68 |
| Revenue Growth | N/A | ★ 3.64 |
| 52 Week Low | $1.31 | $15.88 |
| 52 Week High | $7.80 | $21.78 |
Technical Indicators
Market Signals| Indicator | PEPG | ECBK |
|---|---|---|
| Relative Strength Index (RSI) | 40.74 | 56.01 |
| Support Level | $2.24 | $20.03 |
| Resistance Level | $3.05 | $21.77 |
| Average True Range (ATR) | 0.23 | 0.54 |
| MACD | -0.02 | 0.12 |
| Stochastic Oscillator | 13.64 | 82.02 |
Price Performance
Historical ComparisonAbout PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company. The firm, through its subsidiary, engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, multifamily real estate loans, construction and land loans, and home equity lines of credit.